Zhejiang NHU Company Ltd.

002001.SZ · Shenzhen Stock Exchange · CNY

26,07CNY

+0,07 (+0,27 %)Stand 10. Nov., 7:04

Vortag 26,00

Kennzahlen

Eröffnung
26,00
Vortag
26,00
Tagesspanne
25,74 – 26,17
52 Wochen
23,81 – 40,19
Volumen
16,89 Mio.
Ø Volumen
28,37 Mio.
Börsenwert
80,12 Mrd. CNY
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
0,3
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang, China, specializes in the nationwide production and distribution of a broad spectrum of chemical products. Its principal operations are divided into four main categories: 1. Nutritional Products: The company offers a comprehensive range of supplements, including essential vitamins (E, A, C, D3, biotin), DL-Methionine, coenzyme Q10, and various carotenoids. These ingredients are critical for enhancing animal feed and fortifying food, beverages, and health-related products. 2. Flavors and Fragrances: This segment supplies a variety of aroma chemicals, such as derivatives from the linalool and citral series, cis-3-hexenol, methyl dihydrojasmonate, raspberry ketone, and ligustral, which are widely utilized in personal care items, cosmetic formulations, and food flavorings. 3. New Polymer Materials: Zhejiang NHU provides advanced polymer solutions like polyphenylene sulfide and polyphthalamide. These materials find essential applications across industries including electronics, automotive manufacturing, and environmental protection. 4. Active Pharmaceutical Ingredients (APIs): The company manufactures crucial pharmaceutical components, including moxifloxacin hydrochloride, vitamin A, and vitamin D3, which serve as foundational substances for the development and production of various drug preparations.

CEO
Hu Baifan
Mitarbeitende
11.508
Hauptsitz
Xinchang, ZH, CN
Sektor
Healthcare
Branche
Drug Manufacturers - Specialty & Generic
Börsengang
25. Juni 2004
Website
cnhu.com

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.